These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7498305)
1. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Li XS; Wang QD; Pernow J Eur J Pharmacol; 1995 Sep; 283(1-3):161-8. PubMed ID: 7498305 [TBL] [Abstract][Full Text] [Related]
2. The nonpeptide endothelin receptor antagonist bosentan enhances myocardial recovery and endothelial function during reperfusion of the ischemic rat heart. Wang QD; Li XS; Pernow J J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S445-7. PubMed ID: 8587441 [TBL] [Abstract][Full Text] [Related]
3. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879 [TBL] [Abstract][Full Text] [Related]
4. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Wang QD; Li XS; Lundberg JM; Pernow J Cardiovasc Res; 1995 Jun; 29(6):805-12. PubMed ID: 7656284 [TBL] [Abstract][Full Text] [Related]
6. Effects of the ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischaemia and oedema in the rat. Filep JG; Fournier A; Földes-Filep E Br J Pharmacol; 1995 Sep; 116(2):1745-50. PubMed ID: 8528554 [TBL] [Abstract][Full Text] [Related]
8. Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle. Herbert KJ; Hickey MJ; Lepore DA; Knight KR; Morrison WA; Stewart AG Eur J Pharmacol; 2001 Jul; 424(1):59-67. PubMed ID: 11470261 [TBL] [Abstract][Full Text] [Related]
9. Role of endothelin during reperfusion after ischemia in isolated perfused rat heart. Dagassan PH; Breu V; Clozel M; Clozel JP J Cardiovasc Pharmacol; 1994 Dec; 24(6):867-74. PubMed ID: 7898067 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart. Gonon AT; Bulhak A; Bröijersén A; Pernow J Br J Pharmacol; 2005 Mar; 144(6):860-6. PubMed ID: 15685207 [TBL] [Abstract][Full Text] [Related]
12. Role of L-arginine in preventing myocardial and endothelial injury following ischaemia/reperfusion in the rat isolated heart. Li XS; Uriuda Y; Wang QD; Norlander R; Sjöquist PO; Pernow J Acta Physiol Scand; 1996 Jan; 156(1):37-44. PubMed ID: 8866884 [TBL] [Abstract][Full Text] [Related]
13. Endothelin A and B receptor antagonist bosentan reduces postischemic myocardial injury in the rat: critical timing of administration. Xia Z; Kuo KH; McNeill JH; Ansley DM Can J Physiol Pharmacol; 2005 Mar; 83(3):259-66. PubMed ID: 15870840 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of bosentan, a mixed endothelin type A and B receptor antagonist, during myocardial ischaemia and reperfusion in rats. Singh AD; Amit S; Kumar OS; Rajan M; Mukesh N Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):604-10. PubMed ID: 16700825 [TBL] [Abstract][Full Text] [Related]
15. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion. Gonon AT; Wang QD; Pernow J Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311 [TBL] [Abstract][Full Text] [Related]
16. Characterization of endothelin-1-induced vascular effects in the rat heart by using endothelin receptor antagonists. Wang QD; Li XS; Pernow J Eur J Pharmacol; 1994 Dec; 271(1):25-30. PubMed ID: 7698210 [TBL] [Abstract][Full Text] [Related]
17. Thimerosal attenuates ischaemia-reperfusion arrhythmias in rats: no modification by anti-ischaemic agent trimetazidine or endothelin receptor antagonist bosentan. Iskit AB; Guc MO Pharmacol Res; 1996; 34(1-2):17-23. PubMed ID: 8981551 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest. Goodwin AT; Amrani M; Gray CC; Chester AH; Yacoub MH Eur J Cardiothorac Surg; 1997 May; 11(5):981-7. PubMed ID: 9196318 [TBL] [Abstract][Full Text] [Related]
19. Bosentan affects 15-F2t-isoprostane adverse effects on postischemic rat hearts. Liu HM; Liu KX; Cheng MH; Liu Y; Lei S; Irwin MG; Xia Z J Surg Res; 2011 Jun; 168(1):18-26. PubMed ID: 20006348 [TBL] [Abstract][Full Text] [Related]
20. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Böhm F; Settergren M; Gonon AT; Pernow J Clin Sci (Lond); 2005 Apr; 108(4):357-63. PubMed ID: 15610070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]